Thyroid Eye Disease: Multidisciplinary Management of Treatment-Associated Hearing Loss (CE Monograph)
This educational activity is intended to help clinicians evaluate real-world data pertaining to hearing dysfunction associated with thyroid eye disease treatment with the insulin-like growth factor 1 receptor antagonist teprotumumab.
Category
  • Optometry
Format
  • Monograph
Credits
  • 1.50 COPE
Pinning Down Presbyopia Management: New and Emerging Pharmacologic Treatments (CE Monograph)
This is Part 2 of a 2-part educational activity series designed to enable optometrists to successfully implement pharmacologic treatments for presbyopia for appropriately selected patients.
Category
  • Optometry
Format
  • Monograph
Credits
  • 1.00 COPE
Unlocking Optimal Strategies in Treating DED: Evaporation Is Key (Online CE Monograph)
This educational activity will present an overview of dry eye disease pathophysiology, which will provide a foundation for targeted treatment selection, results from clinical trials of new and emerging treatments, and a series of case-based discussions.
Category
  • Optometry
Format
  • Monograph
Credits
  • 2.00 COPE
Thyroid Eye Disease: Multidisciplinary Management of Treatment-Associated Hyperglycemia (CE Monograph)
This educational activity is intended to help clinicians identify patients with thyroid eye disease who require intervention for elevated blood glucose levels prior to treatment for thyroid eye disease with the insulin-like growth factor 1 receptor antagonist teprotumumab.
Category
  • Optometry
Format
  • Monograph
Credits
  • 1.50 COPE

Pages